Reckitt Benckiser Group plc Sponsored ADR (RBGLY)
OTC PINK OTC PINK Primary 
Reckitt Benckiser Group Plc. ADR (RBGLY) Focus On Emerging Markets: Growth Opportunities and Strategic Capabilities Discussion Transcript
Reckitt Benckiser Group Plc. ADR (RBGLY) Focus On Emerging Markets: Growth Opportunities and Strategic Capabilities Discussion Transcript
Reckitt steadies its course as bank lifts target
Reckitt Benckiser Group PLC's (LSE:RKT, ETR:3RB) turnaround may finally be gaining traction. RBC Capital Markets has raised its price target from £60 to £64 and reiterated an outperform rating, arguing that the consumer goods group is building a record of reliable mid-single-digit growth and improved execution under its “Fuel for Growth” plan.
Reckitt Benckiser Group Plc. ADR (RBGLY) Q3 2025 Sales Call Transcript
Reckitt Benckiser Group Plc. ADR (OTCPK:RBGLY) Q3 2025 Sales Call October 22, 2025 3:30 AM EDT Company Participants Nicholas Ashworth - Head of Investor Relations Kris Licht - CEO & Executive Director Shannon Eisenhardt - CFO & Executive Director Conference Call Participants Guillaume Gerard Delmas - UBS Investment Bank, Research Division Warren Ackerman - Barclays Bank PLC, Research Division David Hayes - Jefferies LLC, Research Division Celine Pannuti - JPMorgan Chase & Co, Research Division Jeremy Fialko - HSBC Global Investment Research Edward Lewis - Rothschild & Co Redburn, Research Division Rashad Kawan - Morgan Stanley, Research Division Tom Sykes - Deutsche Bank AG, Research Division Presentation Nicholas Ashworth Head of Investor Relations Good morning, everybody, and welcome to Reckitt's Q3 trading update.
Reckitt Benckiser sales swell faster than expected as Durex and Dettol outperform
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) reported a stronger-than-expected sales performance in the third quarter, helped by a return to growth in developed markets. The FTSE 100-listed consumer health and hygiene company reported net revenues of £3.6 billion, a 7.0% rise on a like-for-like basis, supported by strong growth in its core products.
Reckitt Benckiser's performance not to be sniffed at, says leading bank
There's nothing like a sniffle season to remind investors of Reckitt Benckiser Group PLC's (LSE:RKT, ETR:3RB) place in the bathroom cabinet. The maker of Nurofen, Dettol and Durex is due to update the market on 22 October, and UBS reckons the numbers will show a business picking up pace after a sluggish start to the year.
Reckitt Benckiser Group PLC (RBGLY) Is Up 1.56% in One Week: What You Should Know
Does Reckitt Benckiser Group PLC (RBGLY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Reckitt Benckiser Group (RBGLY) Upgraded to Buy: Here's Why
Reckitt Benckiser Group (RBGLY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Are You Looking for a Top Momentum Pick? Why Reckitt Benckiser Group PLC (RBGLY) is a Great Choice
Does Reckitt Benckiser Group PLC (RBGLY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Reckitt Benckiser Group PLC (RBGLY) Is Up 11.73% in One Week: What You Should Know
Does Reckitt Benckiser Group PLC (RBGLY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Reckitt upgrades outlook as core business shines and savings drive pays off
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) latest results have drawn a warm response from the City, with both UBS and Barclays highlighting strong momentum in the company's core business and a promising upgrade to full-year guidance. While overall like-for-like sales growth of 1.9% in the second quarter was only a touch ahead of expectations, the standout performance came from Core Reckitt, which delivered 5.3% organic growth, well ahead of what analysts had pencilled in.
Reckitt shares surge 9% as upgraded outlook and profit growth boost confidence
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) shares jumped 9% in early Thursday trading after the group upgraded its outlook for 2025, underpinned by a strong set of half-year results. The company now expects like-for-like (LFL) net revenue growth of between 3% and 4% for the year, and is targeting more than 4% growth for its core Reckitt business, signalling renewed confidence after a period of transformation.
Reckitt to divest Essential Home unit to Advent in deal worth up to $4.8B
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) has signed an agreement to divest its Essential Home business to Advent International for an enterprise value of up to US$4.8 billion. The deal also includes Reckitt retaining a 30% equity stake in the new entity, aligning with its strategy to become a more focused consumer health and hygiene company.
